DORWOAH COUNTS: Open Payments
NPI 1205020237 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 33 payments from 16 companies in 2025. Trend: 2023 $266 · 2024 $1,160 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $170 |
| Esperion Therapeutics, Inc. | 4 | $114 |
| Novo Nordisk Inc | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| CeQur Corporation | 1 | $50 |
| Amgen Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| ABIOMED | 1 | $31 |
Products named: FREESTYLE LIBRE 3, NEXLETOL, Kerendia, FARXIGA, Ozempic, CeQur Simplicity, LEQVIO, REPATHA.
Industry payments across SC — which companies pay providers there.
